Researchers at Rutgers Robert Wood Johnson Medical School have identified immune cells in the intestine that are needed to prevent inflammatory bowel disease (IBD), colitis and Crohn’s disease, which affect 3 million people in the United States.
New study identifies potential treatment for inflammatory bowel disease
Researchers at Rutgers Robert Wood Johnson Medical School have identified immune cells in the intestine that are needed to prevent inflammatory bowel disease (IBD), colitis and Crohn's disease, which affect 3 million people in the United States.